Sign Up to like & get
recommendations!
0
Published in 2017 at "Haemophilia"
DOI: 10.1111/hae.13105
Abstract: The development of neutralizing antibodies (inhibitors) against coagulation factor VIII (FVIII) is currently the most serious complication for patients with haemophilia A undergoing FVIII replacement therapy. Several genetic factors have been acknowledged as risk factors…
read more here.
Keywords:
antibodies brothers;
factor viii;
viii antibodies;
factor ... See more keywords